Home Trending Stocks You Do Not Want To Miss The Gain Train At AC Immune...

You Do Not Want To Miss The Gain Train At AC Immune SA (NASDAQ: ACIU)

AC Immune SA (NASDAQ: ACIU) stock is trading up 143.4% to $17.80 in the morning session today. A closer look at the stock price shows that it is currently trading 43.61% above its three-month low. Taking a broader perspective, the stock is trading at a 28.12% discount to its 52-week high and 129.59% above its 52-week low.

 Company Info.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Nasdaq-listed AC Immune SA (NASDAQ: ACIU) aims to become the world’s leading precision drug company for neurodegenerative diseases. In addition to designing and developing small molecule and biological therapeutics, the Company uses two proprietary platforms, SupraAntigen and Morphomer, to diagnose, prevent and treat neurodegenerative diseases caused by misfolded proteins.

Latest Development

February 11, 2021, AC Immune SA (NASDAQ: ACIU) has reported positive preliminary results from Phase 1b/2a clinical trials examining ACI-35.030 as a potential first-in-class treatment Alzheimer’s disease (AD). Antigen-specific antibodies were generated against pTau in 100% of elderly patients with early AD following vaccination with ACI-35.030, leading to antibody levels 1000 times higher than pre-vaccination levels. These results suggest that ACI-35.030 could treat AD as they observed no clinically relevant adverse events. AC Immune and its strategic partner Janssen Pharmaceuticals, Inc., believe these interim findings support their plans to further develop this drug.

 

The anti-Tau vaccine represents a novel treatment approach for treating Alzheimer’s disease and other neurodegenerative diseases characterized by Tau pathology. ACI-35.030 is a unique vaccine candidate that targets pTau proteins in the brain to produce a specific antibody response. An antibody derived from ACI-35.030 may reduce pTau pathology, a major hallmark of AD.

 

The new results show that ACI-35.030 works well in patients with compromised immune systems using a new vaccine formulation that has been demonstrated to achieve increasing antibody response levels. Anti-pTau vaccination produces antibody responses that differ considerably from the Company’s anti-Tau monoclonal antibody semorinemab, showing how exhaustive and complimentary AC Immune’s anti-Tau pipeline is.

 

Conclusion

During an era of medical science where fresh ways are being discovered to treat and prevent diseases previously unimaginable, biotech stocks allow investors to make a killing.

 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam